🇫🇷·1d agoResearch
Cancer Cell - Une étude française perce le mécanisme d’action d’un médicament innovant chez des patients atteints d’un cancer du poumon au stade avancé
Publisher
I
Institut Gustave Roussy
France
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on gustaveroussy.fr
Leave the platform to read the original full article on the publisher site.
Source: Institut Gustave Roussy
Scope: Research
Related coverage
More related coverage
Fraunhofer Life Sciences·7h ago
Water, Energy, Circularity: Technologies for a Resilient Future
Pharmaceutical Technology·7h ago
FDA approves MSD’s once-daily HIV combo Idvynso
Universitätsklinikum Erlangen·7h ago
Bösartige Weichgewebetumoren besser behandeln
ClinicalTrialsArena·7h ago